MSB 3.21% $1.13 mesoblast limited

Presentation, page-2

  1. 30,371 Posts.
    lightbulb Created with Sketch. 1855
    Great. Nobody else should read the presentations either. Let's all just assume that MSB presentations are a complete waste of time.

    Let's also pretend that MSB isn't negotiating with big pharmas. And one key one Celgene has extended the scope of applications, which is why they asked for an extension of time.

    It's all irrelevant. Let's just read HC posts instead of researching.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.